tiprankstipranks
Trending News
More News >
Advertisement

SMIN - ETF AI Analysis

Compare

Top Page

SMIN

iShares MSCI India Small Cap ETF (SMIN)

Rating:59Neutral
Price Target:
The iShares MSCI India Small Cap ETF (SMIN) has a moderate overall rating, reflecting a mix of strengths and challenges among its holdings. Embassy Office Parks REIT stands out as a key contributor due to its strong financial performance, reasonable valuation, and healthy dividend yield, which positively impact the fund's rating. However, weaker holdings like Glenmark Pharmaceuticals, with profitability volatility and bearish momentum, may have held back the ETF’s overall score. Investors should note the potential risks of overvaluation across several holdings and the concentration in small-cap Indian stocks, which can lead to higher volatility.
Positive Factors
Strong Sector Diversification
The ETF is spread across multiple sectors, including materials, healthcare, and financials, reducing reliance on any single industry.
Focused Geographic Exposure
With nearly all assets invested in India, the fund provides targeted exposure to a growing emerging market economy.
Healthy Top Holdings Performance
Several top holdings, such as Fortis Healthcare and Laurus Labs, have shown strong year-to-date gains, supporting the fund’s potential recovery.
Negative Factors
High Expense Ratio
The ETF charges a relatively high fee compared to many other funds, which can eat into investor returns over time.
Weak Overall Performance
The fund has struggled recently, with negative year-to-date and three-month returns, signaling potential challenges in the small-cap segment.
Over-Concentration in India
The ETF’s heavy focus on Indian stocks limits diversification and increases vulnerability to country-specific risks.

SMIN vs. SPDR S&P 500 ETF (SPY)

SMIN Summary

The iShares MSCI India Small Cap ETF (SMIN) is an investment fund that focuses on small companies in India, offering exposure to the country’s fast-growing economy. It follows the MSCI India Small Cap Index, which includes businesses across various sectors like healthcare, financials, and technology. Some of its well-known holdings include Fortis Healthcare and Federal Bank. This ETF is ideal for investors looking to diversify their portfolio and tap into the growth potential of smaller, innovative companies in emerging markets. However, it’s important to note that small-cap stocks can be more volatile, meaning their value may rise and fall quickly.
How much will it cost me?The iShares MSCI India Small Cap ETF (SMIN) has an expense ratio of 0.75%, meaning you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because it is an actively managed fund focusing on small-cap stocks in India, which require more research and management compared to passively managed funds.
What would affect this ETF?The iShares MSCI India Small Cap ETF (SMIN) could benefit from India's strong economic growth and increasing innovation in sectors like technology and healthcare, which are key areas of exposure for the fund. However, risks include potential regulatory changes in India, global economic uncertainty, and the inherent volatility of small-cap stocks, which can be more sensitive to market fluctuations. Investors should also consider how interest rate changes or inflation could impact sectors like financials and consumer goods within the ETF.

SMIN Top 10 Holdings

The iShares MSCI India Small Cap ETF (SMIN) is riding the wave of India’s dynamic small-cap sector, with standout performers like Federal Bank and Laurus Labs driving gains thanks to their strong financial momentum and bullish technical signals. However, names like Coforge and KEI Industries are holding the fund back, with valuation concerns and mixed performance weighing on their contributions. The ETF leans heavily into financials and materials, reflecting India’s growth story, but its concentrated exposure to small-cap volatility means investors should brace for both exciting highs and potential dips.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Coforge Limited1.74%$13.43M₹625.64B-5.35%
73
Outperform
Federal Bank Ltd. (India)1.43%$11.06M₹655.71B34.69%
64
Neutral
Max Financial Services Limited1.37%$10.55M₹584.33B54.02%
59
Neutral
Laurus Labs Ltd.1.09%$8.43M₹574.05B88.37%
66
Neutral
Embassy Office Parks REIT1.07%$8.24M₹405.80B14.54%
76
Outperform
Glenmark Pharmaceuticals Limited0.93%$7.16M₹575.29B33.23%
53
Neutral
KEI Industries Limited0.81%$6.25M₹424.67B5.51%
63
Neutral
Multi Commodity Exchange of India Limited0.79%$6.13M₹551.61B70.62%
72
Outperform
L&T Finance Ltd0.78%$6.02M₹758.80B118.89%
62
Neutral
UNO Minda Limited0.76%$5.86M₹747.38B22.26%
66
Neutral

SMIN Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
71.08
Negative
100DMA
71.39
Negative
200DMA
71.06
Negative
Market Momentum
MACD
-0.49
Negative
RSI
54.32
Neutral
STOCH
80.20
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMIN, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 69.34, equal to the 50-day MA of 71.08, and equal to the 200-day MA of 71.06, indicating a neutral trend. The MACD of -0.49 indicates Negative momentum. The RSI at 54.32 is Neutral, neither overbought nor oversold. The STOCH value of 80.20 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SMIN.

SMIN Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$756.91M0.75%
$9.43B0.62%
$643.57M0.65%
$197.69M0.78%
$177.84M0.80%
$128.46M0.75%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SMIN
iShares MSCI India Small Cap ETF
70.46
-4.49
-5.99%
INDA
iShares MSCI India ETF
INDY
iShares India 50 ETF
PIN
Invesco India ETF
NFTY
First Trust India NIFTY 50 Equal Weight ETF
GIND
Goldman Sachs India Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement